BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10768842)

  • 21. [Cyclin-dependent kinase inhibitors in mammal cells].
    Jiang H; Wang YC
    Sheng Li Ke Xue Jin Zhan; 1996 Apr; 27(2):107-12. PubMed ID: 9592231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative detection and quantitation of human CDK inhibitor mRNA expression of p15INK4B, p16INK4A, p16beta, p18INK4C, p19INK4D, p21WAF1, p27KIP1 and p57KIP2 by RT-PCR using a polycompetitive internal standard.
    Schwaller J; Pabst T; Bickel M; Borisch B; Fey MF; Tobler A
    Br J Haematol; 1997 Dec; 99(4):896-900. PubMed ID: 9432039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts.
    Carbone CJ; Graña X; Reddy EP; Haines DS
    Cancer Res; 2007 May; 67(9):4130-7. PubMed ID: 17483323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
    Zindy F; Soares H; Herzog KH; Morgan J; Sherr CJ; Roussel MF
    Cell Growth Differ; 1997 Nov; 8(11):1139-50. PubMed ID: 9372237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M; Xiong Y
    Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells.
    Enomoto K; Mimura T; Harris DL; Joyce NC
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4330-40. PubMed ID: 17003423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The lack of G1/S arrest of teratocarcinoma F9 cells is determinated by degradation of cyclin-dependent kinases inhibitor p21waf1/cip1].
    Malashicheva AB; Kisliakova TV; Pospelov VA
    Tsitologiia; 2000; 42(5):433-40. PubMed ID: 10890048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression.
    Quereda V; Martinalbo J; Dubus P; Carnero A; Malumbres M
    Oncogene; 2007 Dec; 26(55):7665-74. PubMed ID: 17599058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
    Gray-Bablin J; Rao S; Keyomarsi K
    Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.
    Cánepa ET; Scassa ME; Ceruti JM; Marazita MC; Carcagno AL; Sirkin PF; Ogara MF
    IUBMB Life; 2007 Jul; 59(7):419-26. PubMed ID: 17654117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells.
    Kang SH; Bang YJ; Jong HS; Seo JY; Kim NK; Kim SJ
    Br J Cancer; 1999 Jun; 80(8):1144-9. PubMed ID: 10376964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC; Chen YQ
    Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of p16INK4a, p15INK4b, p21WAF1/Clip1 cell cycle inhibitors on blastic cells in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) ].
    Kapelko-Słowik K; Wołowiec D; Sedek K; Jaźwiec B; Urbaniak-Kujda D; Kuliczkowski K
    Pol Arch Med Wewn; 2002 Sep; 108(3):849-53. PubMed ID: 12600181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.
    Okuda T; Hirai H; Valentine VA; Shurtleff SA; Kidd VJ; Lahti JM; Sherr CJ; Downing JR
    Genomics; 1995 Oct; 29(3):623-30. PubMed ID: 8575754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease.
    Arendt T; Holzer M; Gärtner U
    J Neural Transm (Vienna); 1998; 105(8-9):949-60. PubMed ID: 9869328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell cycle dysregulation influences survival in high risk breast cancer patients.
    Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
    Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
    Noh SJ; Li Y; Xiong Y; Guan KL
    Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle regulation during mouse olfactory neurogenesis.
    Legrier ME; Ducray A; Propper A; Chao M; Kastner A
    Cell Growth Differ; 2001 Dec; 12(12):591-601. PubMed ID: 11751454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.